7 September 2021
Dechra® Pharmaceuticals PLC
(Dechra or the Company)
Availability of 2021 Annual Report and Accounts
The 2021 Annual Report and Accounts is now available to view at www.dechra.com.
The following documents are scheduled to be mailed to registered shareholders of the Company on 20 September 2021:
· 2021 Annual Report and Accounts
· Notice of the 2021 Annual General Meeting; and
· Proxy Form for the 2021 Annual General Meeting.
In accordance with Listing Rule 9.6.1 a copy of each of these documents will be submitted to the National Storage Mechanism and will be available for viewing shortly after posting.
For further information, please contact:
Melanie Hall, Company Secretary
Telephone number: +44 (0) 1606 814730
Dechra is a global specialist veterinary pharmaceuticals and related products business. Our expertise is in the development, manufacture, marketing and sales of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products. For more information please visit: www.dechra.com
Trademarks appear throughout this document in italics. Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.